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Cone/usiorrs:After nonradio8cfive stenting, residual lumen area iscloaely
modeled by a negative exponential function over a wide spectrum of vascular
injury. 1.5 yCi V* stente had no effect on lumen narrowing or vessel histol-
ogy. 10 &Ci V4 stente had a larger residual lumen due to Iese neointimal
thickening than controls. This benefit is moat pronounced for grade 2 and 3
injury.
a97359 BeteIrradiationfor ReetenoeiaAfterStentImplantation:DoaeVariationsAmongDiffering
Stente
J. Weinberger, S. Mirzadeh, F.F.R.Knapp, H. Amols. Co/umbia University
New York, NY USA, Oak Ridge National Laboratory Oak Ridga, TN, USA
Background: Intraluminal irradiation has bean propoaad for the treatment of
restenoeis. We ahow here that uniformity of radiation dose ie pertwbed if
the radioactive source is insertad peat stent implantation. There is significant
difference amono varioue stent and even with high trsnamisaion, stenta are
Gafchromic doeimetryfilm was used to meaeure the doae distribution around
an angioplaafy catheter filled with a edution of a beta emitter (>2 MeV
treneition energy), with and without an interposed stent. We assayed the
following etente: J&J, Instent, Nin Wiktor, Wallatent, ACS and Cordis stenta.
The film wae scanned with a 600 dpi scanner. Results: Analyeis of the
exposed films revealed local cold spots in the dose distribution. The depth
of the cold apote varied among the varioue stents, with three classes of
doea ehadow minima: stents with Iese than a 5% ahadow, stents with --
10% shadow, and thoee with 20% or greater shadows. The depth of the
shadow was calculated as a percent of the maximum adjac8nt dose, caused
by absorption by and shadowing of the stent wires. At distances >0.75
mm radial to the balloon, electron scattering largely obliterates the pattern
of stent shadowing, yielding a more uniform dose distribution. Cone/uaion:
Theae obsewationa have impettant implications for the dosing of radiation
in the presence of various stenta, and for the selection of stenta with the
intention to subsequently treat with intravascular radiation. In areas of atent
overlap these considerations may be of even greater magnitude.
D97360 Low-doeefl-EmlttlngRadioactiveStenteInhibitNeointimalHyparpiaaiain PorcineCoronary
Arteries:an HistologicalAssessment
A. Rivard, G. Leolero, M. Bouchard, G. Beaudoin, R. Carrier, C. Janicki,
S. Roorda. Notre-Dame Hospita/and Urrivarsityof Montraa/, Montr.4a/,
Qu&rec, Canada
p-emitting redioactivs atents (RS) have been proposed to prevent neointimal
hyperplaeia (NIH) after angioplasty. The effectiveness of thia strategy in
coronary arteriea and the extent to which NIH is inhibited in the prosthesis
haayattobedemonstrated by pathological analysie.Accordingly,the purpose
of this study wee to evaluate the effectiveness of low-dose RS to prevent
reetenosis in porcine right coronary arteriee (RCA) and to quantify the extent
of NIH by anaiysis of hiatologioal sections of the treated arteries. A total of
12 Palmaz-Schatz stents (PS-153) were implanted in 12 coronary arteries
from 6 piga. RS were obtained by P-32 direct ion implantation (mean activity:
0.6 #Ci/stent with homogeneousdistribution). RS were all deployed in RCA
(n= 6) and 6 non-radioactive stents (NRS) were implanted in left coronary
arteries (LCA) (5 Cx, 1 LAD). Stenta were deployad using a balloon-to-artery
ratio of 1.18 in RCA and 1.19 in LCA (p = NS). Three weeks following
stenting, pigs were sacrificed and the treated atteries were preeaure fixed in
10% formaline. A total of 60 histological sections were obtained from each
artery (5 eections per stent). Evaluation of the neointimal area wee done
by mmputer assisted imaging. All stented arteries were patent at the time
of examination. Neointimal area was significantly lower in the RS treatad
arIeries when compared to NRS (1.91 & 0.14 mmz va 2.61 + 0.24 mrr? p
= 0.03). This reduction of NIH was homogeneous throughout the length of
both half stente. The RSalao showad a significant reduction in the neointimal
area at the implant bridge section (1.49 + 0.27 mm2 vs 2.55 + 0.37 mti
p = 0.045). COnCh.Si~: Low-dose ~-emitting radioactive atents significantly
reduce neointimal hyperpiasia in porcine coronaty arteriee, thia raduotion
being homogenoua throughout the Palmaz-Schatz stent.
1973-61I BiodegradabieStentCoatingWithPolylacticAcid,
HirudinandProstacylinReducesRestenoais
E. Alt, C. Seilharz, D. Preter, G. Schmidmaier, J. Pasquantonio, W. Erhard,
A. Stembergerl, A. Schomig. L Med. Klirrik, Inst., Technkzha UniveraiW
Mihrchen, GamrarrH11.Med. Klinik, inst. for Exp. Surgery Technische
Univeraitilt MWrchen, Germany
Background: With mronary stenting acute and subacute stent thromboaie
and amooth muscle cell proliferation continue to be of concern. The goal
of this study was to evaluate a newly developed polylactic acid (PLA) atent
coating (25 kDa) eluting hirudin and a prostecyclin analog in comparison to
uncoated stents with respect to restenosis in corona~ arteries.
Methods: Standard Palmaz-Schatz atents were coated with a 10 #m thin
Iayerof PLA (200 #g) eiuting 10 #g PEG -hirudin and 2 ~g of the prostaoyclin
analog PG12. 16 coated and 16 uncoated stents were randomiy assigned to
LAD or LCX and impianted in 16 sheep with a standard ballmn inflated to
10 atm, aiming for a balloon to vessel ratio of 1.3. After 30 days the stents
were explanted for histomorphometric analysis. Lumen, neointima, media,
and stent dimensions were determined for four cross sections per stent.
Resu/ts: There were no significant differences between the two groups
with respect to implant characteristics.
Mean diameter &SD Uncoated stent Coatsd stent
Lumenat implant(mm) 2.s1 * 0.13 ns 2.90+0,2S
Lumenday 30 (mm) 2.17 * 0.32 * 2.44 +0.45
Mean neointimalthickness 320 + 112 * 233+93
Restenoaia(O/.) 22.95 * 16.14
*p <0.02
Conclusion: Coating of mronary artery etente with PLA eluting both a
thrombin and a platelet inhibitor exhibits a favorable effect on neointimal
formation and reduces restenoiis by .29.i’Yoin the animal model.
1973-621 DoesLocallontophoreticLowhlolecularWeight
HeparinDeliveryReduceNeointimalFormation
AfterStenting?
J. Grt!goire, M.H. Jeong, A.R. Camrud, L.J. Camrud, D.R. Holmes Jr,
R.S. Schwartz. Mayo Clinic, Rochastec MN,USA
Low Molecular Weight Heparin (LMWH) inhibits smooth muscle cell prolifera-
tion in addition to its anticoagulant effects. We therefore teeted iontophoraais
as a novel, local delivety approach since this technique markedly enhancea
arterial wall drug levels. The study was performed in a porcine restenoeis
model using oversized stents. Thirty pigs were studied and divided into 4
groupe as foilows: Gr/(7 pigs, 13 arteries) LMWH 10 IU/kg-hr systemic infu-
sion for24 hrfollowed by70 IU/kg sq BID days 2-21. Gr/1(8pigs, 16 arteriee)
local LMWH deiivery with current (5 mA for 1 min. 30 see) 7000 IU/cc before
injury and then 70 IU/kg sq BID days 1-21. Gr/// (8 pigs, 16 arteries) local
LMWH delivery without current and then as in Grll, and Gr/V (7 pige, 13
arteries) stent only (control). Pigs were euthanized at 28 days and histologic
analysis performed. Results:
InjuryScore” NI Thickness(mm)
Gr I 1,39 + 0.6S 0.46 + 0.20
Gr II 1,51 + 0.63 0.5s * 0.21
Gr Ill 1,03 + 0.60 0.43 + 0.16
Gr IV 1,52 A 0.60 0.55 * 0.1s
*O = No lesion,1 = IEL rupture,2 = 1 + medial disruption,3 = 2 + EEL rupture
There was no significant difference between groups for NI thickness
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and injury. Conclusion: LMWH given systemically or locally, with or without
iontophoresis did not limit neointimal thickness in this stent model. This result
suggest that clinical triala of LMWH may be similarfy negative.
D97363 Predictors of Terget Vesssl ReveecularizstionFollowing Coronary Stent Deployment
K.M. Ziada, M.H. Kim, W. Potts, A.C. De France, P.L.Whitlow, S.G. Ellis,
S.E. Nieeen, E.M. Tuzcu. The Cleveland Clinic Foundation, C/eve/and,
Ohio, USA
Objective: We aought to determine the clinical, angiographic and ultrasound
predictors of target vessel revascularfzation (lVR) after coronary stenting.
Mathods: All ‘patients who underwent ultrasound-guided 1 or 2 stent
implantation over a 14 month period were included in this atudy. Clinical
and angiogrephic date were prospectively colleeted in a dedicated database.
Intravascular ultrasound analysis of the stented aegments was performed in
a core laboratory. Patients were followed for TVR over 8.0+ 2.4 months.
Resu/ts: Of 239 consecutive study patients, TVR was performed in 32
(13%). No clinieel characteristics or rkskfactors were predictive of TVR. The
effects of other variables on the probability of TVR follows:
Odds Rstio 95%C.I.
(Per 1 SD)
AngicgrephicVariables
Decreasingreference diameter 1.6 1,1-2.6
Increasingbaseline % diamsterstenosis 1.7 1.1-2.5
Increasingbaaeiine lesion length 1.5 1.1-2,5
Distalflowat baseline -=TIMI3 5.0 1.7-14
Ostial locationof Issions 2.9 1.1-7.5
Dewessingflnal YOdiamefarstenoeis 1.2 0.85-1.8
FinalLfftrasoundVariables
Decreasingminimumstent Ium%ndiamster 2.1 1A-3.3
Decreasingminimumstent lumen area 2.2 1.4-3.8
Dacreaaingfinal ‘h diamslerstenoeis 1,1 0.78-1.7
Dacressingfinal 0/0area stenosis 1.3 0.88-1.9
Conclusions.’ Pre-intervention angiographic variablea, particularly TIMI
flow and oetial location, predict TVR. Post-stent percent atenosie by an-
giography or ultrasound do not impact outcome. However, absolute in-stent
lumen area, measured by ultrasound, is an important determinant of TVR.
D97364 Influence of Lesion Length on Late AngiographicOutcome and Restenotic Process After Successful
Stent Implantation
N. Hameeaki, H. Noeaka, T. Kitnura, Y. Nakagawa, H. Yokol, T. Tamura,
M. Nobuyoshi. Kokurs Memorial Hospital, Japan
The purpose of the preeent study waa to investigate the influence of lesion
length on late angiographic outcome and restenoais proceasafter successful
atent placement. The etudy population compriaed 461 consecutive Iesiona
implanted native arteries at elective aituation (Palmez-Schatz stent 401,
Cordis stent 50) and satisfactory angiographic analysie before, after stenting
and 3 or6 rnonthefollow-up (FUP) in a single center (Feb. 199&Feb. 1995).
Total occlusion at baseline and follow-up were excluded. The patients were
divided into 3 groups according to lesion length and following variables were
compared.
Lesioniength 1) <7.5 mm 2) 7.5-14.9 mm 3)2 15.Om P
No. of lesion 145 255 51
No. of stent 1.0 * 0.2 1.0* o 1.3+ 0.5 <OLIOO1
Veeeeisize(mm) 3.22 4c0.58 3.21 kO.54 3.20+0.85
MLD pre(mm) 0.94+0.38 0.83*0.38 0.77* 0.40 0.0JJ6
MLD poet(mm) 2.95+0,38 2.89 & 0.42 2.77+ 0.51 0.03
Acute gain (mm) 2.01 + 0.48 2.08 +0.48 2.00+ 0.47
MLD FUP(mm) 2.15+ 0.68 2.06+0.71 1.80+ 0.75 0.009
Latelose(mm) 0.80&0.80 0.83+0.59 0.97* 0.75
Raafenoaia(50%s) 15% 207. 31% 0.01
No:number,MLD:MinimalLumenDiameter.
Late angiographic outcome auch as MLD at follow-up and binary reeteno-
eis rate correlated closely with lesion length. Leeion length was found to be
exert a significant positive effect on late Ioasbut not in acute gain by univari-
able and multivariable (p c 0.001) analysis. The relative gairrloes relationship
within the groups showed that it vary with the lesion length (group 1) r. loss=
0.31 r. gain+ 0.08, group 2) y = 0.23x + 0.11, group 3) y = 0.48x + 0,01). In
conclusion, lesion length itself influence on both late angiographic outcome
and restenosie process. One should be carefully weighed in selection of the
patients.
1973-651 Are ACC/AHALeeionCheracteristicsPredictivefor
Late Angiographic Results After Coronary Stent
Plecsment?
H. SchOhlen,J. Hausleiter, S. Elezi, A. Wehinger, H. Walter, J. Direchinger,
A. Schdmig. Deutsches Herzzentrum Mtinchen, Garman~ Mediziniacha
Klinik, TechnischaUnivereitat, Munich, Genrrany
ACC/AHA lesion characteriatice describe the complexity of etenosee to pre-
dict the outcome after PTCA. This retrospective study analyzes the quantita-
tive angiographic 6-month follow-up (FU) of 588 Ieeions in 529 patients with
eucceesfulcorona~ stent placement (p-values ae calculated by ANOVA).
A (n = 30) B1 (n= 49) B2 (n =204) C (n = 305) p
MLD pre (mm) 0.86 + 0,67 0.79+ 0.34 0.60+ 0.53 0.68 +0.46 <0,05
RD pre (mm) 2.98 + 0.67 2.96+ 0.50 3.06+ 0.57 3.04 +0.56 na
Number of stenta 1.3 l 0.5 2,5 +2.0 2.6+ 1.5 3.0 + 1.6 <0.05
Ballootieaael 1,10 +0.13 1.12 +0.14 1.11 + 0.19 1.15 +0.17 ne
Acute gain (mm) 2.07+0.54 2.12 + 0S3 2.43+0.65 2.37+0.82 <0.05
MLD post(mm) 2.93+ 0.56 2.91 + 0.46 3.03+0.50 3,05+ 0.33 na
RD post (mm) 2.96+ 0.58 3.05 + 0.51 3.17+ 0.49 3.17* 0.057 na
MLD FU (mm) 2.19+ 1,00 1.96+ 0.60 2.06+0.92 1.90 l 0.91 na
RD FU (mm) 3.01 + 0.61 2.92+ 0.57 3.03+ 0.54 3.05 +0.56 na
Late loss(mm) 0.73 + 0.80 0.95+ 0.83 0.97+ 0.61 1.15 +0.83 <0.05
Restenosisrste 23,3% 20,4% 22.6% 31.8”A na
Cone/usions:Thedifferences in acute data refkscttheACC/AHAgrading of
stenoees.Late Iosaiesignificantly higher in complex stenoses with a trend for
higher restenosis rates. Theee data euggeet that Iesiona of high ACC/AHA-
grading also have a poorer long-term angiographic outcome after scenting.
1973-661Long-Ter~clinica,outcomeein’’~ow-R,s~’’and
“High-Risk” Patients Undergoing Coronary Stent
Implantation
M.K. Hong, G.S. Mintz, J.J. Popma, K.M. Kent, A.D. Pichard, L.F. Satler,
T. Bucher, A. Greenberg, K. Morgan, T. Weaver, K. Donovan, M.B. Leon
Washington Hospital Centac Washington, DC, USA
Previously we ehowed that low-risk pta undergoing “optimal” Palmez-Schatz
stent implantation (ultrasound guidance and 216 atm adjunct PTCA) with
reduced antieoagulation (aspirin andticlopidine only) had excellent acute and
long-term outcomee. To determine the outcomes in “high risk” pte, defined
es (1) auboptimal implantation (poor apposition or incomplete expenaion),
(2) Z3 atente, or (3) thrombus @ Ieaion site (or peri-infarction), treated with
extended anticoagulation (aepirin, ticlopidine, and Lovenox’” for2 weeka), we
asseaeed early and late (>6-month) clinical events in a consecutive seriea
of 1322 native coronary and SVG Palmaz-Schafz stent pta.
Native Coronaries SVG’e
Low-risk High-risk Low-risk High-risk
(N =417) (N-= 547) (N= 134) (N-=224)
MC/SAT (%) 0.7/0.6 0.9/0.2 0.7/0.7 0.9/0.4
TLR (“A)‘ “’ 11.7 19.3* 14.3 11.2
Re-PTCA (“A) 8.5 13.0” 9.1 7.6
CABG (“A) 3.6 7.1* 5.7 4.4
MC= major implications (death, Ml, CABG); SAT = subacutethrombosis;TLR = target
I&ion reveacutarization;” p <0.05 vs. low-riskgroup.
/n conchsion: After ultrasound guided stent implantation, (1) both low-
and high-rfek groups had excellent acute outcomea, but (2) high-risk native
coronary pts had aignificently greater TLR.
1973-671 CliniCelandAngiOgraPhic Restenosi~ After
Coronary Stenting. Incidence and Predictors
J.J.AlonSO,J.M. Dur~n, F. Gimeno, J. Bermejo, L Garcimatrin, L. Fuente,.
J.C. Mufloz, F. Femandez-Avilea. Hospital Universitario, Va//ado/id,Spain
To assess the incidence and predictors of restenosi8 (R) after coronary
stenting (CS), we studied the evolution of 415 stented Iesiona from 373
consecutive pts (61 + 10 yr, 87% male). A total of 469 stents (Palmaz-
Schatz: 93% Wiktor: 7%) were implanted (1.13 stentilesion). In 63% of pts,
PTCA was done due to unetable angina. Indications for CS were: restenosie
14%, “bail-out” 31%, suboptimal result 6%, and “de novo” lesions 49%. The
left anterior descending artery was the most frequently stented (54%).
Angiographic follow-up (FU) at 6 months was done in 940/. of iesions.
Clinical FU was completed in 94Y0of pte. Angiographic R (>50% criterion,
QCA)occurred in23%of lesions (Cl 957.: 19-28%) but only 35 pts developed
angina (clinical R: 11%, Cl 95%: 8-15%). Univariate analysis of 33 clinical,
angiographic and procedural variables showed that type C lesions (p= 0.04),
number of stents per lesions (p = 0.02), diabetes (p = 0.02), minimal Iuminal
